Multitude Therapeutics Inc.
Clinical trials sponsored by Multitude Therapeutics Inc., explained in plain language.
-
New drug duo takes on advanced lung cancer
Disease control Not yet recruitingThis study tests a new combination of two drugs, AMT116 and ivosimab, in people with advanced non-small cell lung cancer that cannot be removed by surgery. The goal is to find the safest dose and see if the combination shrinks tumors. About 118 adults aged 18 to 75 will take part…
Phase: PHASE1, PHASE2 • Sponsor: Multitude Therapeutics Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
New hope for advanced colon cancer: experimental combo enters phase 2 trial
Disease control Not yet recruitingThis study tests a new drug called AMT-676 combined with standard chemotherapy and targeted therapy for people with advanced colorectal cancer that cannot be removed by surgery. The goal is to see if the combination is safe and helps shrink tumors or slow the disease. About 180 a…
Phase: PHASE2 • Sponsor: Multitude Therapeutics Inc. • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC